XOLAIR
Live / Registered — Registered — international registration renewed (as of 27 Jun 2025)
What this means for you
Registered since 23 Jul 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79250398
- Registration number
- 5809618
- Mark type
- Design + words
- Filed
- 30 Oct 2018
- Published for opposition
- 07 May 2019
- Registered
- 23 Jul 2019
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of severe allergic reactions following exposure to an allergen
Owner
- Novartis AG, CH
- Novartis AG, CH
- Novartis AG, CH
Prosecution history
- 27 Jun 2025 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 27 Jun 2025 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 26 Jun 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 14 Mar 2025 — TEAS SECTION 71 & 15 RECEIVED
- 23 Jul 2024 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 12 Aug 2021 — INTERNATIONAL REGISTRATION RENEWED
- 30 Nov 2019 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 13 Nov 2019 — FINAL DISPOSITION NOTICE SENT TO IB
- 13 Nov 2019 — FINAL DISPOSITION PROCESSED
- 23 Oct 2019 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 23 Jul 2019 — REGISTERED-PRINCIPAL REGISTER
- 07 May 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 May 2019 — PUBLISHED FOR OPPOSITION
- 17 Apr 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Mar 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER